Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Applauds Introduction of Bipartisan…
BIO President and CEO John F. Crowley today released the following statement after a bipartisan group of Senators, Sen. Bob Casey (D-PA), Sen. Markwayne Mullin (R-OK), Sen. Sherrod Brown (D-OH), and Sen. Susan Collins (R-ME), introduced the Creating…
Learn more
BIO International Convention Celebrates Another…
Biotechnology Innovation Organization (BIO) is proud to conclude the 2024 BIO International Convention in San Diego, held last week June 3-6, 2024. 1,400 exhibitors and more than 19,500 attendees from 70 countries came together for four full days of…
Learn more
BIO Recognizes Industry Leaders for…
WASHINGTON - June 5, 2024 – The Biotechnology Innovation Organization (BIO) today announced the winners of the organization’s 2024 Leadership in Agri-Biotechnology Awards — honoring Dr. Annette Kleiser, CEO of Dalan Animal Health, as the recipient…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
America’s Biopharmaceutical Companies Working Around the Clock to Beat Coronavirus
March 20, 2020
Companies are Coming Together to Achieve Shared Goal of Eradicating the Virus  Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO) underscored the industry’s commitment…
Maine Takes Significant Step in Addressing Climate Challenge Through Renewable Chemicals Tax Credit
March 19, 2020
Maine is speeding up its transformation to a 21st-century, biobased economy with the passing of the Renewable Chemicals Tax Credit, which will foster the production of environmentally friendly innovations—like renewable chemicals and biobased…
Media Advisory: World’s Largest Biopharmaceutical Organization to Host Two-Day Virtual Summit on Coronavirus
March 18, 2020
BIO-Led Summit to Build Collaboration Between Biopharma Industry, Government Leaders & Scientific Experts  Responding to the rapidly evolving COVID-19 public health crisis, the Biotechnology Innovation Organization (BIO) is taking the…
SEC Regulatory Changes Provide Small Biotech Companies Relief from Burdensome Requirements
March 12, 2020
The Securities and Exchange Commission (SEC) has adopted regulatory changes to provide small public companies with a temporary exemption from Sarbanes-Oxley 404(b) compliance. 404(b) requires public companies to report on the internal controls they…
BIO Statement Urging USDA Adoption of Pre-Market Notification Process within Biotech Reg System
March 6, 2020
Washington, D.C. (March 6, 2020) – The following statement can be attributed to Dana O’Brien, BIO’s Executive Vice President for Food & Agriculture urging USDA to establish a pre-market notification process within its plant biotechnology…
BIO Asia Conference in Tokyo Cancelled Amid COVID-19 Outbreak
February 21, 2020
Washington, DC – February 21, 2020 - The Biotechnology Innovation Organization (BIO) announced today, it is canceling the annual BIO Asia conference in Tokyo scheduled for March 10-11. The decision was based on the global impact of COVID-19 and…
A Patient Advocate’s Perspective on Foreign Price Controls
February 7, 2020
In a new video, Cynthia Bens, patient advocate and Senior Vice President of Public Policy at the Personalized Medicine Coalition, shares her views on how adopting foreign price controls for prescription medicines will impact patients in the U.S. …
Patients, Scientists and Researchers Will Be Watching the State of the Union
February 4, 2020
Ahead of tonight’s State of the Union Address, Jim Greenwood, President and CEO of the Biotechnology Innovation Organization, shared what he hopes President Trump will say to America’s patients counting on the development of new medicines and cures,…
Adopting foreign price controls “prevents investors from being able to invest, and inventors from being able to invent.”
February 3, 2020
In a new video, Alex Karnal, a life science investor and partner at Deerfield Management, shares why investing in new cures and treatments is personal, and he explains how President Trump’s plan to import foreign price controls would have an …
Biotech Leader Rachel King Urges President Trump to Reject Foreign Price Controls, Ensure U.S. Continues to Lead in Innovation
January 31, 2020
Rachel King is co-founder and CEO of GlycoMimetics, a biotech company based in Rockville, Maryland that is working hard to develop new treatments for patients with various diseases of the blood. In a new video, Mrs. King explains why President Trump…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today